LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 11 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 1. - Dataset (ID:20248)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | Neratinib | 1.11 | uM | LJP5 | 72 | hr | 513 | 712 | 10362 | 0.0688 | 0.0762 |
MCF 10A | Neratinib | 3.33 | uM | LJP5 | 72 | hr | 513 | 683 | 10362 | 0.0659 | 0.0680 |
MCF 10A | Neratinib | 10 | uM | LJP5 | 72 | hr | 513 | 664 | 10362 | 0.0640 | 0.0595 |
MCF 10A | JW-7-24-1 | 0.04 | uM | LJP6 | 72 | hr | 513 | 9324 | 10473 | 0.8905 | 0.9473 |
MCF 10A | JW-7-24-1 | 0.12 | uM | LJP6 | 72 | hr | 513 | 9173 | 10473 | 0.8762 | 0.9394 |
MCF 10A | JW-7-24-1 | 0.37 | uM | LJP6 | 72 | hr | 513 | 8077 | 10473 | 0.7714 | 0.8834 |
MCF 10A | JW-7-24-1 | 1.11 | uM | LJP6 | 72 | hr | 513 | 6953 | 10473 | 0.6641 | 0.8199 |
MCF 10A | JW-7-24-1 | 3.33 | uM | LJP6 | 72 | hr | 513 | 5711 | 10473 | 0.5455 | 0.7397 |
MCF 10A | JW-7-24-1 | 10 | uM | LJP6 | 72 | hr | 513 | 604 | 10473 | 0.0577 | 0.0378 |
MCF 10A | Dasatinib | 0.04 | uM | LJP5 | 72 | hr | 513 | 4779 | 10362 | 0.4612 | 0.6727 |
MCF 10A | Dasatinib | 0.04 | uM | LJP6 | 72 | hr | 513 | 1706 | 10473 | 0.1629 | 0.3169 |
MCF 10A | Dasatinib | 0.12 | uM | LJP5 | 72 | hr | 513 | 1768 | 10362 | 0.1705 | 0.3292 |
MCF 10A | Dasatinib | 0.12 | uM | LJP6 | 72 | hr | 513 | 741 | 10473 | 0.0708 | 0.0875 |
MCF 10A | Dasatinib | 0.37 | uM | LJP5 | 72 | hr | 513 | 792 | 10362 | 0.0764 | 0.1048 |
MCF 10A | Dasatinib | 0.37 | uM | LJP6 | 72 | hr | 513 | 525 | 10473 | 0.0502 | 0.0043 |
MCF 10A | Dasatinib | 1.11 | uM | LJP5 | 72 | hr | 513 | 654 | 10362 | 0.0631 | 0.0526 |
MCF 10A | Dasatinib | 1.11 | uM | LJP6 | 72 | hr | 513 | 410 | 10473 | 0.0392 | -0.0505 |
MCF 10A | Dasatinib | 3.33 | uM | LJP5 | 72 | hr | 513 | 337 | 10362 | 0.0325 | -0.0932 |
MCF 10A | Dasatinib | 3.33 | uM | LJP6 | 72 | hr | 513 | 305 | 10473 | 0.0291 | -0.1141 |
MCF 10A | Dasatinib | 10 | uM | LJP5 | 72 | hr | 513 | 332 | 10362 | 0.0320 | -0.0967 |
MCF 10A | Dasatinib | 10 | uM | LJP6 | 72 | hr | 513 | 217 | 10473 | 0.0207 | -0.1805 |
MCF 10A | Tozasertib | 0.04 | uM | LJP5 | 72 | hr | 513 | 1653 | 10362 | 0.1594 | 0.3083 |
MCF 10A | Tozasertib | 0.12 | uM | LJP5 | 72 | hr | 513 | 1287 | 10362 | 0.1243 | 0.2362 |
MCF 10A | Tozasertib | 0.37 | uM | LJP5 | 72 | hr | 513 | 1079 | 10362 | 0.1041 | 0.1863 |
MCF 10A | Tozasertib | 1.11 | uM | LJP5 | 72 | hr | 513 | 1080 | 10362 | 0.1041 | 0.1855 |